These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 28552573
1. Evaluation of the Clinical Utility of Renin-Angiotensin System Inhibitors in Patients Undergoing Radical Surgery for Urothelial Carcinoma of the Upper Urinary Tract. Yoshida T, Matsuzaki T, Murota T, Kawa G, Matsuda T, Kinoshita H. Clin Genitourin Cancer; 2017 Dec; 15(6):e943-e954. PubMed ID: 28552573 [Abstract] [Full Text] [Related]
2. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study. Liu JY, Dai YB, Zhou FJ, Long Z, Li YH, Xie D, Liu B, Tang J, Tan J, Yao K, He LY. BMC Surg; 2017 Jan 17; 17(1):8. PubMed ID: 28095848 [Abstract] [Full Text] [Related]
3. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Kim JK, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH. Urol Oncol; 2017 Jul 17; 35(7):458.e9-458.e15. PubMed ID: 28347659 [Abstract] [Full Text] [Related]
4. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study. Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. World J Urol; 2017 Oct 17; 35(10):1569-1575. PubMed ID: 28397000 [Abstract] [Full Text] [Related]
5. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. Fairey AS, Kassouf W, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf JB, Saad F, Drachenberg D, Cagiannos I, Lacombe L, Fradet Y, Jacobsen NE. BJU Int; 2013 Oct 17; 112(6):791-7. PubMed ID: 23148712 [Abstract] [Full Text] [Related]
6. Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study. Murakami Y, Matsumoto K, Ikeda M, Hirayama T, Utsunomiya T, Koguchi D, Matsuda D, Okuno N, Taoka Y, Irie A, Iwamura M. Int J Clin Oncol; 2019 Nov 17; 24(11):1412-1418. PubMed ID: 31197556 [Abstract] [Full Text] [Related]
7. Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy. Yoshida T, Kinoshita H, Fukui K, Matsuzaki T, Yoshida K, Mishima T, Yanishi M, Komai Y, Sugi M, Inoue T, Murota T, Matsuda T. Ann Surg Oncol; 2017 Mar 17; 24(3):823-831. PubMed ID: 27730369 [Abstract] [Full Text] [Related]
8. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. Kim HS, Ku JH, Jeong CW, Kwak C, Kim HH. World J Urol; 2016 Jun 17; 34(6):859-69. PubMed ID: 26497823 [Abstract] [Full Text] [Related]
9. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis. Chung HS, Hwang EC, Kim MS, Yu SH, Jung SI, Kang TW, Choi C, Choi SH, Kwon TG, Noh JH, Kim MK, Cho WJ, Kang SG, Kang SH, Cheon J, Seo IY, Chung H, Kim HS, Lee CH, Ku JY, Ha HK, Kim BH, Jeong CW, Ku JH, Kwak C, Kwon D. Clin Genitourin Cancer; 2019 Jun 17; 17(3):e394-e407. PubMed ID: 30782419 [Abstract] [Full Text] [Related]
10. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Shibing Y, Turun S, Qiang W, Junhao L, Haichao Y, Shengqiang Q, Ping H, Dehong C. Urol Oncol; 2015 May 17; 33(5):204.e9-16. PubMed ID: 25800374 [Abstract] [Full Text] [Related]
11. Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Lim JH, Jeong IG, Park JY, You D, Hong B, Hong JH, Ahn H, Kim CS. Korean J Urol; 2015 Jul 17; 56(7):498-504. PubMed ID: 26175868 [Abstract] [Full Text] [Related]
12. Preoperative Pyuria Is a Poor Prognostic Factor in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Surgery. Yoshida T, Kinoshita H, Shimada S, Sugi M, Matsuda T. Clin Genitourin Cancer; 2017 Aug 17; 15(4):e543-e550. PubMed ID: 28110834 [Abstract] [Full Text] [Related]
13. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy. Zhai TS, Jin L, Zhou Z, Liu X, Liu H, Chen W, Lu JY, Yao XD, Feng LM, Ye L. BMC Cancer; 2019 Dec 12; 19(1):1207. PubMed ID: 31830927 [Abstract] [Full Text] [Related]
14. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C. Urol Oncol; 2013 Nov 12; 31(8):1615-20. PubMed ID: 22521771 [Abstract] [Full Text] [Related]
15. Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma. Yamada Y, Ikeda M, Hirayama T, Murakami Y, Koguchi D, Matsuda D, Okuno N, Taoka Y, Utsunomiya T, Irie A, Matsumoto K, Iwamura M. Asia Pac J Clin Oncol; 2023 Jun 12; 19(3):305-311. PubMed ID: 35909301 [Abstract] [Full Text] [Related]
16. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma. Ikeda M, Matsumoto K, Sakaguchi K, Ishii D, Tabata KI, Kurosawa K, Urakami S, Okaneya T, Iwamura M. Clin Genitourin Cancer; 2017 Oct 12; 15(5):556-562. PubMed ID: 28501481 [Abstract] [Full Text] [Related]
17. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K. Urol Oncol; 2017 Sep 12; 35(9):539.e9-539.e16. PubMed ID: 28499734 [Abstract] [Full Text] [Related]
18. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma. Xu H, Ai JZ, Tan P, Lin TH, Jin X, Gong LN, Lei HR, Yang L, Wei Q. Asian J Androl; 2020 Sep 12; 22(2):177-183. PubMed ID: 31169138 [Abstract] [Full Text] [Related]
19. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma. Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C. Int J Clin Oncol; 2018 Aug 12; 23(4):726-733. PubMed ID: 29435873 [Abstract] [Full Text] [Related]
20. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy. Kobayashi Y, Arai H, Hamamoto Y, Yoshida K, Shimizu S, Yasuhara Y, Ichimaru N. Clin Genitourin Cancer; 2023 Oct 12; 21(5):e386-e393. PubMed ID: 37244798 [Abstract] [Full Text] [Related] Page: [Next] [New Search]